|
Delayed
Australian S.E.
12:40:39 15/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 171.89 AUD | +0.19% |
|
-1.54% | -0.32% |
| 10:40am | Paradigm Biopharmaceuticals Names Chief Medical Officer | MT |
| 14/09 | ASX Midday Sector Update: Healthcare Stocks Advance, Materials Sector Struggles | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 57.4B | |||||
| 78.04B | |||||
| 57.48B | - | ||||
| 48.81B | |||||
| 45.5B | |||||
| 32.08B |
- Stock Market
- Stocks
- CSL Stock
- Charts CSL Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
